Gunzburg assessed the possibility of COVID-19 transition into a seasonal disease
Alexander Gintsburg, director of the Gamaleya Research Center for Epidemiology and Microbiology, assessed the possibility of COVID-19 becoming a seasonal ...
Alexander Gintsburg, director of the Gamaleya Research Center for Epidemiology and Microbiology, assessed the possibility of COVID-19 becoming a seasonal ...
The head of the Gamaleya Center for Epidemiology and Microbiology, Alexander Gintsburg, has named a method of 100% protection against ...
At present, there are no scientific prerequisites for the fact that the coronavirus pandemic can end on the omicron strain. ...
The nasal vaccine against coronavirus, developed by scientists from the Gamaleya Center for Epidemiology and Microbiology, will be two-component. This ...
The Gamaleya Center has begun clinical trials of a drug against coronavirus infection based on monoclonal antibodies. This was announced ...
The head of the Gamaleya Center for Epidemiology and Microbiology, Alexander Gintsburg, revealed the timing of the start of clinical ...
The site is functioning with financial support of the federal agency by press and massive communications. Registered by the Federal ...
Those vaccinated with Sputnik V are unlikely to get COVID-19 caused by the Omicron strain. Alexander Gintsburg, director of the ...